Letter to the Editor: The efficacy of BNT162b2 (Pfizer-BioNTech) and CoronaVac vaccines in patients with cancer

J Med Virol. 2023 Mar;95(3):e28664. doi: 10.1002/jmv.28664.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • BNT162 Vaccine*
  • Humans
  • Neoplasms* / therapy

Substances

  • BNT162 Vaccine
  • sinovac COVID-19 vaccine